MedPath

Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate

Completed
Conditions
Amyotrophic Lateral Sclerosis
Registration Number
NCT01955369
Lead Sponsor
Klinikum Ludwigshafen
Brief Summary

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria
  • minimum of 18 years
  • minimum of 6 months of residency in Rhinelnad-Palatinate
Exclusion Criteria
  • patients below 18 years
  • ALS patients outside Rhineland-Palatinate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deathan average of 3 years

death of participating ALS patients independent of the cause of death

Secondary Outcome Measures
NameTimeMethod
Tracheostomyan average of 3 years

tracheostomy in ALS patients following respiratory failure

Trial Locations

Locations (1)

Dept. of Neurology, Klinikum Ludwigshafen

🇩🇪

Ludwigshafen, Germany

© Copyright 2025. All Rights Reserved by MedPath